Stay updated on Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a backend/frontend update. There is no evident change to the study details, enrollment criteria, or other user-facing content.SummaryDifference0.1%

- Check11 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2 on the page, indicating a minor document update.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedEnrollment status updated to indicate recruitment has ended. The page also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header formatting, with the revision label changed to v3.6.0.SummaryDifference0.5%

- Check32 days agoChange DetectedRevision: v3.5.5 was added and Revision: v3.5.4 was removed, indicating the page's revision tag was updated. This reflects a new revision deployment affecting the page's metadata rather than its content.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4 on the page, indicating a new version of the page. This is a minor, administrative update rather than a substantive change to the study content.SummaryDifference0.1%

- Check75 days agoChange DetectedThe publications section citation for the related Oncologist article was updated to reflect the finalized issue date/details instead of an online-ahead-of-print entry. The page revision/version label was also updated (v3.5.2 to v3.5.3).SummaryDifference0.1%

Stay in the know with updates to Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial page.